<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Ben-Shalom Lab</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
  <div class="banner">
    <video class="banner-video" src="videos/homepage.mp4" autoplay muted loop playsinline></video>
    <div class="banner-title">Lab News</div>
  </div>
  <div class="navbar">
  <a href="index.html">Home</a>
  <a href="research.html">Research</a>
  <a href="team.html">Our Team</a>
  <a href="publications.html">Publications</a>
  <a href="news.html">News</a>
  <a href="positions.html">Open Positions</a>
  <a href="contact.html">Contact</a>
  </div>
  <div class="content">
    <h1>News!</h1>
    
    
    <div class="intro-box">

<!--New News Section ------------------------------------------------------->
  
<div class="news-event-date">September 20, 2025</div>
  <div class="news-event-title"> Roy's Nature Paper was published!</div>
  <div class="news-event-content">
    Abstract:<br><br>
    Most neurodevelopmental disorders with single gene diagnoses act via haploinsufficiency, in which only one of the two gene copies is functional1. SCN2A haploinsufficiency is one of the most frequent causes of neurodevelopmental disorder, often presenting with autism spectrum disorder, intellectual disability and, in a subset of children, refractory epilepsy2. Here, using SCN2A haploinsufficiency as a proof-of-concept, we show that upregulation of the existing functional gene copy through CRISPR activation (CRISPRa) can rescue neurological-associated phenotypes in Scn2a haploinsufficient mice. We first show that restoring Scn2a expression in adolescent heterozygous Scn2a conditional knock-in mice rescues electrophysiological deficits associated with Scn2a haploinsufficiency (Scn2a+/−). Next, using an adeno-associated virus CRISPRa-based treatment in adolescent mice, we show that we can correct intrinsic and synaptic deficits in neocortical pyramidal cells, a major cell type that contributes to neurodevelopmental disorders and seizure aetiology in SCN2A haploinsufficiency. Furthermore, we find that systemic delivery of CRISPRa protects Scn2a+/− mice against chemoconvulsant-induced seizures. Finally, we also show that adeno-associated virus CRISPRa treatment rescues excitability in SCN2A haploinsufficient human stem-cell-derived neurons. Our results showcase the potential of this therapeutic approach to rescue SCN2A haploinsufficiency and demonstrates that rescue even at adolescent stages can ameliorate neurodevelopmental phenotypes.
<img src="images/news/roynature092025.png " alt="Nature Paper" style="display:block;margin:24px auto;max-width:80%;height:auto;border-radius:12px;" />

  Check out the full paper here:
      <div class="publication-box">Serena Tamura, Andrew D Nelson, Perry WE Spratt, Elizabeth C Hamada, Xujia Zhou, Henry Kyoung, Zizheng Li, Coline Arnould, Vladyslav Barskyi, Beniamin Krupkin, Kiana Young, Jingjing Zhao, Stephanie S Holden, Atehsa Sahagun, Caroline M Keeshen, Congyi Lu, <b>Roy Ben-Shalom</b>, Sunrae E Taloma, Selin Schamiloglu, Ying C Li, Lia Min, Paul M Jenkins, Jen Q Pan, Jeanne T Paz, Stephan J Sanders, Navneet Matharu, Nadav Ahituv, Kevin J Bender. CRISPR activation for SCN2A-related neurodevelopmental disorders. Nature (2025). <a href="https://doi.org/10.1038/s41586-025-09522-w">https://doi.org/10.1038/s41586-025-09522-w </a>
      </div>
  </div>
  <hr style="border: none; border-top: 2px solid #5c5c5c; margin: 100px 0 100px;"> <!-----------------separator line-------------->

<!-------------------------------------------------------------------------->

  <div class="news-event-date">September 18, 2025</div>
  <div class="news-event-title">Kaustubh, Giselle, and Tim will present at SfN's Neuroscience 2025 Meeting
  </div>

  <div class="news-event-content">
  Come find their posters in the following sessions:<br><br>
  <u>Giselle</u><br>
  Session Name: Epilepsy Networks and Post-Seizure Modifications<br>
  Session Number: PSTR205<br>
  Session Date & Time: Monday, November 17, 2025, 1:00 PM – 5:00 PM<br><br>
  <u>Kaustubh</u><br>
  Session Name: Computational Approaches and Experimental Analyses I<br>
  Session Number: PSTR145<br>
  Session Date & Time: Sunday, November 16, 2025, 1:00 PM – 5:00 PM<br><br>
  <u>Tim</u><br>
  Session Number: PSTR316<br>
  Session Title: Voltage-Gated Sodium Channels<br>
  Session Day & Time: Tuesday, November 18, 2025, 1:00 PM – 5:00 PM<br>

  <hr style="border: none; border-top: 2px solid #5c5c5c; margin: 100px 0 100px;">. <!---------------separator line-------------->
  </div>  
<!-------------------------------------------------------------------------->


    
</div>    


</body>
</html>
